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How cell type-specific differences in chromatin
conformation are achieved and their contribution to
gene expression are incompletely understood. Here
we identify a cryptic upstream orchestrator of inter-
feron-g (IFNG) transcription, which is embedded
within the human IL26 gene, compromised of a single
CCCTC-binding factor (CTCF) binding site and re-
tained in all mammals, even surviving near-complete
evolutionary deletion of the equivalent gene encod-
ing IL-26 in rodents. CTCF and cohesins occupy
this element in vivo in a cell type-nonspecific manner.
This element is juxtaposed to two other sites located
within the first intron and downstream of Ifng, where
CTCF, cohesins, and the transcription factor T-bet
bind in a T helper 1 (Th1) cell-specific manner. These
interactions, close proximity of other elements within
the locus to each other and to the gene encoding
interferon-g, and robust murine Ifng expression are
dependent on CTCF and T-bet. The results demon-
strate that cooperation between architectural (CTCF)
and transcriptional enhancing (T-bet) factors and the
elements to which they bind is required for proper
Th1 cell-specific expression of Ifng.
INTRODUCTION
Naive CD4+ T cells can differentiate into one of several helper cell
lineages, including T helper 1 (Th1) and Th2 cells, whose distinct
functions allow them to play nonredundant roles in host defense
(Zhu and Paul, 2008). The functional specialization of T helper
cells results from differences in the abundance of lineage-
specific transcription factors and from T helper cell subset-
specific epigenetic modifications that collaborate to initiate and
to maintain appropriate programs of gene expression (Lee et al.,
2006; Wilson et al., 2009; Zhu and Paul, 2008). These epigenetic
modifications includeDNAmethylation, posttranslational histonemodifications, nucleosome position and density, and higher-
order structural organization of the genome. The latter mecha-
nism has received increasing attention of late, after the recogni-
tion that the three-dimensional structure of DNA can be altered
in a cell type-specific manner through chromatin looping to bring
distal regulatory elements in proximity to one another and the
promoters of their target genes, or vice versa, to facilitate proper
expression (Apostolou and Thanos, 2008; Decker, 2008; Fraser
and Bickmore, 2007; Lee et al., 2006). In the immune system,
such structural changes may be important for properly ordered
T cell receptor and immunoglobulin gene rearrangement and
for Th2 cytokine gene expression (Cai et al., 2006; Lee et al.,
2006; Skok et al., 2007; Spilianakis and Flavell, 2004).
The murine Th2 cytokine locus contains the Il4, Il5, and Il13
genes and the constitutively expressed Rad50 gene. The linear
relationships between these genes are conserved in mammals,
and in part for this reason, the Th2 cytokine locus has provided
an important model for identifying distal cis-regulatory elements
and for elucidating the mechanisms by which they coordinately
regulate nearby clustered genes (Ansel et al., 2006). Coordinate
regulation of these genes may be achieved in part through
chromatin looping, which can bring the Il4, Il5, and Il13 gene
promoters into proximity to each other and to the Th2 cytokine
locus control region (LCR) to promote their expression (Cai
et al., 2006; Spilianakis and Flavell, 2004).
By contrast to the Th2 cytokine locus where coexpressed
cytokine genes are clustered together, the nearest upstream
neighbors of human IFNG that encodes the signature Th1 cyto-
kine IFN-g are IL22 and IL26. These genes encode cytokines
expressed mainly by Th17 cells rather than Th1 cells (McGeachy
and Cua, 2008), and the nearest downstream coding gene is
500 kb away. The insertion of repetitive elements and other
complex structural rearrangements beginning 70 kb upstream
of mouse Ifng deleted the gene encoding IL-26, which is absent
in mouse and rat, in a common rodent ancestor (Schoenborn
et al., 2007; She et al., 2008). This observation initially led us
and others to search for cis-regulatory elements proximal to
these structural alterations, resulting in the identification of
several enhancers located within an120 kb region surrounding
mouse Ifng (Hatton et al., 2006; Lee et al., 2004; SchoenbornImmunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc. 551
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T-bet Conditions CTCF-Dependent Regulation of Ifnget al., 2007; Shnyreva et al., 2004). However, there is increasing
evidence that only a fraction of the cis-regulatory elements
responsible for differences in appearance, behavior, function,
and disease risk are identified by such focused experimental
approaches and by searches for regions of extended conserva-
tion of noncoding sequences (CNSs) as compared to unbiased
approaches (Donnelly, 2008; Wray, 2007).
Here, by using next-generation sequencing to map cis-regula-
tory elements (denotedby thepresence ofDNaseI hypersensitive
sites) in an unbiased, high-resolution, and comprehensive
manner,we identify a cryptic IFNG regulatory element embedded
within the neighboring human IL26gene. This element consists of
a single binding site for the insulator factor CTCF. This site is
present in all mammals and has been selectively retained in
rodents despite the lack of surrounding sequence conservation
and near total deletion of the gene encoding IL-26 from their
genomes (Schoenborn et al., 2007; She et al., 2008). This element
was occupied in vivo by CTCF and cohesins, as were two other
elements located within and downstream of human IFNG and
murine Ifng. These three CTCF binding sites and multiple inter-
posed enhancers were juxtaposed to each other and to the Ifng
promoter through Th1 cell-specific chromatin looping. This loop-
ing and robust Ifng expression were dependent on normal levels
of CTCF, and robust CTCF binding and CTCF-dependent chro-
matin looping were in turn dependent on the Th1 cell lineage-
specifying transcription factor T-bet (Szabo et al., 2000). These
results demonstrate that T-bet promotes Ifng expression in part
by facilitating CTCF binding and chromatin looping at the Ifng
locus and also reveal a presumably widespread mechanism of
cooperation between a ubiquitous architectural factor (CTCF)
and a lineage-specific transcriptional enhancer (T-bet) factor in
cell-specific gene regulation.
RESULTS
Cell-Specific Chromatin Accessibility and In Vivo CTCF
Occupancy at the Human IFNG Locus
In rodents, the insertion of repetitive elements and other
structural rearrangements in a common ancestor (Schoenborn
et al., 2007; She et al., 2008) resulted in deletion of the gene
encoding IL-26, which in humans and other mammalian species
is located 40–70 kb upstream of IFNG (Figure 1A). These
alterations make the murine locus difficult to analyze. Thus, to
determine whether cis-regulatory elements might be present in
addition to those previously identified in the mouse Ifng locus
(Hatton et al., 2006; Lee et al., 2004; Schoenborn et al., 2007;
Shnyreva et al., 2004), we performed an unbiased search in the
human IFNG locus, which lacks the upstream structural rear-
rangements and repetitive elements found in the mouse locus.
This was done by applying to human naive, Th1, and Th2 CD4+
T cells an approach we recently developed (digital DNaseI) for
genome-wide high-resolutionmapping of DNaseI hypersensitive
sites (DHSs) (Hesselberth et al., 2009), whichmark cis-regulatory
regions of all types (Stalder et al., 1980; Wu, 1980). This revealed
Th1 cell-restricted DHSs at the promoter andwithin introns 1 and
3 of IFNG, which are orthologous to previously described mouse
Ifng DHSs I, II, and III (Agarwal and Rao, 1998). Human Th1 cells
also exhibited DHSs at 31 kb, 22 kb, 16 kb, 4 kb, +22 kb,
+40 kb, and +80 kb relative to the transcriptional start site of552 Immunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc.IFNG (Figure 1B); only two of these sites were similarly evident
in the other cell types—the DHS at 16 kb was detectable in
naive CD4+ T cells and two of the three DHSs clustered at
+40 kb in Th1 cells were evident in Th2 cells. With the exception
of DHS22, each of these sites corresponds to regions of non-
coding conservation, DHSs, and peaks of T cell subset-specific
chromatin modifications found at orthologous locations in the
mouse Ifng locus (Figure 1A; Hatton et al., 2006; Lee et al.,
2004; Schoenborn et al., 2007; Shnyreva et al., 2004).
Inspection of the digital DNaseI profiles also disclosed a DHS
located 63 kb upstream of human IFNG within the major intron
of IL26, which was strong in Th1 cells and detectable though
very weak in naive and Th2 CD4+ T cells (Figure 1B). This element
and another DHS that was located 119 kb downstream of
human IFNG, and detectable only in Th1 cells, did not coincide
with previously identified mouse Ifng regulatory elements.
Comparative genomic analysis of DHS63 revealed that the
core 20 nucleotides of this element were shared among
mammals (Figure 1D) and had survived the rodent-specific struc-
tural alterations that removed nearly all of IL26. This observation
suggested that this previously cryptic element was functionally
relevant.
Consistent with this possibility, these 20 nucleotides
correspond precisely with a consensus binding site for CTCF
(Figure 1D), a constitutive regulatory factor known to participate
in chromatin looping and chromatin domain formation (Bushey
et al., 2008; Cuddapah et al., 2009; Majumder et al., 2008;
Phillips and Corces, 2009; Splinter et al., 2006). Remarkably,
these nucleotides were precisely and selectively retained in the
mouse within an ancestral remnant of the IL26 gene located 70
kb upstream of Ifng. CTCF binding motifs were also present
within the DHS at +119 and within the Th1 cell-specific DHS
located at +1 kb in intron 1 (Figures S1 and S2 available online),
but not within the other DHSs. To determine whether CTCF
occupied these sites in human Th1 cells, we performed CTCF
ChIP, which demonstrated CTCF occupancy at DHSs 63 kb,
+1 kb, and +119 kb but not at the other DHSs (Figure 1C). These
results demonstrate that CTCF binds at a Th1 cell-specific DHS
within the first intron of human IFNG and to upstream and down-
stream DHSs, including one located in the major intron of IL26.
CTCF Occupies Orthologous Sequences at the Mouse
Ifng Locus and Colocalizes with Cohesins
To determine whether CTCF could bind to orthologous
sequences in mouse cells, we first used electrophoretic mobility
shift assays, which demonstrated binding of recombinantmurine
CTCF to these specific nucleotide sequences (Figure S1).
Binding was blocked by cold competitor oligonucleotides but
not by oligonucleotides in which the central bases of the CTCF
consensus sequence were mutated.
We next performed ChIP in murine naive, Th1, and Th2 CD4+
T cells. CTCF occupancy was detected at the mouse 70 kb
region (orthologous to human DHS63 kb) in naive CD4+
T cells; CTCF occupancy increased modestly and to a similar
degree in Th1 and Th2 cells (Figure 2A). By contrast, CTCF occu-
pancy at +1 kb (located in the first intron of Ifng and correspond-
ing to DHSII) and at +66 kb (the mouse ortholog of human
DHS+119 kb) was somewhat above background in naive CD4+
T cells and was clearly and selectively increased in Th1 but not
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Figure 1. Cell-Specific Chromatin Accessibility and CTCF Occupancy in the IFNG Locus
(A) Schematic depicting the location of the human IL26 and IFNG genes and DNaseI hypersensitive sites found in human Th1 cells (down arrows, shown with
distance from the IFNG 50 end) in relation to the orthologous gene and regulatory elements in the mouse Ifng locus reported previously (Schoenborn et al.,
2007). Nearly all of the mouse gene encoding IL-26 has been deleted as a result of complex structural rearrangements, which include a set of tandem repeats
shown just upstream of the mouse70 kb region where the CTCF-binding site orthologous to the human63 kb CTCF-binding site located in an intron of Il26 is
present. Shown below is PhastCons conservation score and evolutionary conservation relative to mouse, rat, dog, and cow.
(B) Chromatin accessibility shown as the density of mapped DNaseI cleavage sites (in a 150 bp sliding window) from human naive, Th1, and Th2 CD4+ T cells.
DHSs correspond with peaks in the density profiles.
(C) CTCF ChIP analysis in human Th1 cells. Results are the mean ± SD of three experiments.
(D) Zoomed view of conserved CTCF binding motifs within DHSs located in human at 63 kb and mouse at 70 kb relative to IFNG.Th2 cells. CTCF occupancy was not detected at the 22 kb and
+29 kb enhancers.
CTCF has been shown recently to colocalize to a large degree
with cohesins and perhaps to recruit cohesins to specific loca-
tions in the genome (Parelho et al., 2008; Wendt et al., 2008).
Consistent with these findings, when we performed ChIP with
antibodies to the Rad21 component of the cohesin complex,
Rad21 was found to colocalize with CTCF at the Ifng locus(Figure 2B). Thus, CTCF and cohesins co-occupied three sites
at the mouse Ifng locus, which are orthologs of the sites occu-
pied by CTCF in the human IFNG locus.
CTCF Occupancy at the +1 kb and +66 kb Regions
Parallels T-bet Occupancy not DNA Demethylation
We next explored possible mechanisms for differences in
CTCF binding between Th1 and Th2 cells. CTCF is known toImmunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc. 553
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Figure 2. CTCF, Cohesin, T-bet Binding, and DNA Methylation State of CTCF-Binding Sites in the Mouse Ifng Locus
(A) CTCF ChIP analysis in mouse naive, Th1, and Th2 CD4+ T cells. Results are the mean ± SD of three experiments; results are shown relative to the binding of
CTCF at 70 kb in naive T cells, which represented 0.9% ± 0.3% of input and was assigned a value of 1. p values (calculated by Student’s t test)% 0.05 are
shown.
(B) Rad21 (cohesin) ChIP analysis in mouse naive, Th1, and Th2 CD4+ T cells. Results are the mean ± SD of two experiments for naive T cells and three exper-
iments for Th1 and Th2 cells; results are shown relative to the binding of cohesin at 70 kb in naive T cells, which represented 2.6% ± 0.3% of input and was
assigned a value of 1.
(C) CD4+ T cell subset-specific CpG methylation at the CTCF-binding elements as determined by bisulfite sequencing. Arrows mark the positions of predicted
CTCF-binding sites. Hepatocytes were used as a control. Rows, sequences of cloned alleles; filled circles, methylated CpG; open circles, unmethylated CpG.
Below plots, the fraction and percentage of unmethylated CpGs.
(D) T-bet ChIP analysis in mouse naive, Th1, and Th2 CD4+ T cells. Results are the mean ± SD of two experiments for naive T cells and four experiments for Th1
and Th2 cells; results are shown relative to the binding of T-bet at the Ifng promoter (DHSI) in naive T cells, which represented 4.9% ± 0.4% of input and was
assigned a value of 1. ***p < 0.005; **p < 0.01; *p < 0.05.preferentially associate with unmethylated CpG dinucleotides
(Kanduri et al., 2000; Ling et al., 2006), butwe foundno consistent
relationship between CTCF occupancy and CpG methylation at
the70 kb or +66 kb regions, because nearly all CpGs at70 kb
were unmethylated and nearly all at +66 kb were methylated,
regardless of cell type. However, CpGs at +1 kb were unmethy-
lated in aTh1cell-specific fashion (Figure 2C;FigureS2), asprevi-
ously reported for this region (Lee et al., 2006;Wilson et al., 2009).554 Immunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc.Although CTCF occupancy was not clearly correlated with the
degree of DNA demethylation, a relationship was observed
between T-bet andTh1 cell-specificCTCFoccupancy. The+1 kb
and +66 kb regions, whichwere occupied byCTCF and cohesins
in aTh1cell-specificmanner (Figures 2Aand2B),were alsooccu-
pied by T-bet in Th1 cells (Figure 2D). Conversely, T-bet was not
boundat the70 kb region,whereCTCFand cohesin occupancy
was not Th1 cell specific. Nor was T-bet occupancy sufficient for
Immunity
T-bet Conditions CTCF-Dependent Regulation of IfngCTCF binding at the locus, because in Th1 cells (and to a limited
degree in naive CD4+ cells), T-bet but not CTCF occupied the
Ifng promoter (DHSI) and the 22 kb and +18 kb enhancers
(Figures 2A and 2D), which lack CTCF consensus sequences
(not shown). These findings show that CTCF and T-bet have
both distinct and shared binding sites in the Ifng locus, and that
CTCF occupancy of the shared sites is Th1 cell specific.
The CTCF-Binding Sites Can Function as Insulators
CTCF has been reported to be involved in regulatory domain
boundary functions (Phillips and Corces, 2009); therefore, we
tested these three CTCF-binding sites for enhancer blocking
and chromatin barrier activity (Bushey et al., 2008; Gaszner and
Felsenfeld, 2006; Schoenborn et al., 2007). These assays
revealed that the 70 kb CTCF-binding element exhibited both
barrier and enhancer-blocking functions comparable to the
human MYC insulator and superior to the +1 kb and +66 kb
regions (FigureS3). TheseactivitieswereCTCFspecific, because
they were abolished after mutation of the CTCF motifs. We also
testedall of theaforementionedelements for enhancer or silencer
Il22 Iltifb Ifng Tmevpg1
10
20
30
C
ro
ss
lin
ki
ng
 fr
eq
ue
nc
y
0
Naive CD4+ T cells
Th1 cells
Th2 cells
CNS
-54
CNS
-34
CNS
-22
CNS
-6
CNS
+18/20
CNS
+29
CNS
+46-70 +66A
0 20 40 60 80 100-20-40-60-145-233
Distance from Ifng gene (kb)
Bgl II fragment
Naive CD4+ T cells
Th1 cells
Th2 cells
10
0
20
30
C
ro
ss
lin
ki
ng
 fr
eq
ue
nc
y
D
C
10
20
30
C
ro
ss
lin
ki
ng
 fr
eq
ue
nc
y Thymocyte (EL-4)
Th1 clone (AE7)
Th2 clone (D10)
Erythroid (G1E)
0
B
10
20
30
C
ro
ss
lin
ki
ng
 fr
eq
ue
nc
y
0
Th1 cells
Th1 cells (PMA+Iono)
Figure 3. Three-Dimensional Conformation
of the Mouse Ifng Locus
Relative cross-linking frequencies between a fixed
anchor fragment bearing the Ifng gene (A–C) or the
+66 CTCF site (D) and other BglII fragments via
primary mouse naive, Th1, and Th2 CD4+ T cells
(A, B, D), primary mouse Th1 cells with or without
restimulation with PMA + ionomycin for 6 hr
(B), or Th1 (AE7), Th2 (D10G4.1), T progenitor
(EL-4 thymocyte), or erythroid progenitor (G1E)
cell lines (C). Black shading represents the position
of the anchor fragment, and the locations and
widths of gray shading indicate the positions and
sizes of the BglII fragments whose cross-linking
frequency to the anchor fragments was assessed.
The location of the mouse Ifng and Il22 genes and
their orientation are shown in the cartoon above.
Iltifb, a degenerate pseudogene derived from an
inverted duplication of Il22 and located between
Il22 and Ifng, and the annotated noncoding tran-
script Tmevpg1 located downstream of Ifng, are
also shown (Schoenborn et al., 2007). Data (error
bars, SD) are representative of three independent
experiments. Each signal was normalized to
control templates and to interactions within the
Gapdh locus.
activity in vitro, with negative results
(Figure S4). Thus, each of the regions
occupied by CTCF in the Ifng locus had
insulator activity, the strongest of which
was the 70 kb region.
Th1 Cell-Specific Chromatin
Looping in the Ifng Locus
CTCFhasbeenproposed toexert its func-
tional effect on transcription of nearby
genes through a mechanism involving
chromatin looping (Bushey et al., 2008;
Gaszner and Felsenfeld, 2006; Majumder
et al., 2008; Phillips and Corces, 2009; Splinter et al., 2006;
Williams and Flavell, 2008). We therefore used the chromosome
conformation capture (3C) assay (Dekker, 2006; Tolhuis et al.,
2002) to interrogate interactions between Ifng and 350 kb of
surrounding sequences, including the CTCF-binding elements
at 70 kb and +66 kb, other known regulatory elements, and
control regions (Figure S5). This analysis revealed strong inter-
action of the 70 kb and +66 kb sites with Ifng in Th1 cells
(Figure 3A). Two additional regions were also approximated to
Ifng: the 40 to 27 kb fragment, encompassing the conserved
34 kb enhancer, and the broad region containing the conserved
+18/20 kb and+29 kb enhancers. Approximation of these distal
regulatory elements to Ifng and to each other was similar in Th1
cells before and after activation with PMA plus ionomycin
(Figure 3B), aswasCtcf andTbx21 (encoding T-bet)mRNAabun-
dance, whereas expression of Ifng increased >25-fold with acti-
vation (data not shown).
These interactions were reduced in Th2 cells and intermediate
between Th1 and Th2 cells in naive CD4+ T cells (Figure 3A), par-
alleling differences in CTCF occupancy at +1 kb and +66 kb
Immunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc. 555
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T-bet Conditions CTCF-Dependent Regulation of Ifng(Figure 2A). These interactions were also substantially greater in
the AE7 Th1 cell line than in D10 Th2, T cell progenitor (EL-4
thymocyte), or erythroid progenitor (G1E) cell lines (Figure 3C;
Gregory et al., 1999). These findings were reproduced when the
3C assays were done with the +66 kb (Figure 3D) or 70 kb
(Figure S6) CTCF-binding elements rather than Ifng as the
reference point, with the exception that the 34 kb enhancer
interacted less with these CTCF-binding elements than with
Ifng. Thus, Th1 cell-specific chromatin looping and Ifng locus
architecture were established during cellular differentiation and
were not modified further by activation-induced Ifng expression.
shRNA-Mediated Gene Targeting of CTCF Impairs
the 3-Dimensional Conformation of the Ifng Locus
and Ifng Expression
We next sought to determine whether CTCF is required for the
formation of this Th1 cell-specific Ifng locus conformation and
for robust Ifng expression by Th1 cells. Transduction of Th1 cells
with retroviruses expressing CTCF shRNAs (Figure S7) led to
marked (CTCF#1) to moderate (CTCF#2) reductions in CTCF
mRNA and protein compared to cells transduced with the
control retrovirus (Figures 4A and 4B). These reductions were
directly paralleled by reduced interactions between the 70
and +66 kb CTCF-binding elements, by reduced interactions
between these elements, Ifng, and the enhancers interposed
between them (Figures 4C and 4D), and by reduced occupancy
by CTCF at the 70 kb, +1 kb, and +66 kb elements (Figure 4E).
Conversely, shRNA-mediated reduction in CTCF had no effect
on T-bet occupancy (Figure 4F).
The reduced interactions between regulatory elements
observed in Th1 cells transduced with CTCF shRNAs compared
to the control shRNA were paralleled by a reduction in the
percentage of cells producing IFN-g, the amounts produced
per cell (as indicated by the mean fluorescence intensity, MFI)
the amounts secreted into culture supernatants, and Ifng
mRNA abundance (Figures 5A–5C). In contrast to IFN-g, there
was little or no effect of CTCF shRNA on the production of IL-2
(Figures 5A–5C) or TNF (data not shown) or in the fraction of
Th1 cells containing T-bet or amounts of T-bet they contained
(Figure 5D). Tbx21mRNA;mRNAs encoding the Th1 cell-specific
genes Cxcr3, Ccr5, Il12rb2, and Furin; mRNAs of the nearest
upstream (Mdm1, Il22) and downstream (Dyrk2) gene neighbors
of Ifng on mouse chromomome 10; and Gata3 mRNA were
comparably abundant in control and CTCF shRNA-transduced
cells (Figure 5C). Although Stat4 expression was reduced in
CTCF shRNA-transduced cells, this is unlikely to be an important
cause of reduced Ifng expression because expression of Furin,
which is strongly Stat4 dependent (Pesu et al., 2006; Thieu
et al., 2008), was not reduced by CTCF shRNA. Thus, Th1 cell-
specific Ifng locus conformation and robust Ifng expression by
Th1 cells were CTCF dependent, whereas the expression of
Tbx21 and other T-bet-dependent and Th1 cell-specific genes
was not.
CTCF Binding, Th1 Cell-Specific Ifng Locus
Conformation, and Ifng Expression Are Abrogated
in the Absence of T-bet
A major consequence of the CTCF-driven interactions is Th1
cell-specific juxtaposition of the conserved enhancers at34 kb,
556 Immunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc.+18–20 kb, and +29 kb with Ifng (Figure 3). In Th1 cells, CTCF
and T-bet together occupy the +1 kb and +66 kb regions
(Figure 2); the 34 kb, 22 kb, and +18–20 kb enhancers and
the Ifng promoter are also occupied by T-bet (Chang and
Aune, 2005; Hatton et al., 2006; Shnyreva et al., 2004). These
observations suggested that T-bet might potentiate Ifng expres-
sion in part by promoting chromatin looping and CTCF binding.
To test this possibility, we studied interactions in T-bet-deficient
T cells, in which STAT4- and TCR-dependent activation of Ifng
is intact but T-bet-dependent facilitation is absent. Consistent
with previous reports (Szabo et al., 2000; Thieu et al., 2008),
T-bet-deficient Th1 cells produced 4- to 5-fold less IFN-g than
did wild-type cells (Figure 6A). This reduction was paralleled
not only by reduced interactions of these enhancers with Ifng,
but also by reduced interactions of the 70 kb and +66 kb
CTCF-binding elements with Ifng and with one another (Figures
6B and 6C). As a result, and in clear contrast to wild-type cells
(Figure 3), the conformations of the Ifng locus in T-bet-deficient
(Tbx21/) Th1, Th2, and naive CD4+ T cells did not differ greatly
(Figure 6B). Consistent with these effects on chromatin looping,
T-bet was required for the Th1-specific binding of CTCF at the
+1 kb and +66 kb elements but not at the 70 kb element
(Figure 6D), where CTCF occupancy was not Th1 cell specific.
These results suggest that T-bet regulates locus conformation,
at least in part, through control of CTCF binding and CTCF-
dependent chromatin looping.
How might T-bet promote the binding of CTCF to the intronic
and +66 kb elements? We first considered the possibility that
T-bet might interact with CTCF. To address this possibility, we
performed immunoprecipitation followed by immunoblotting
with T-bet and CTCF antibodies. In primary Th1 cells, we readily
detected T-bet but not CTCF in T-bet immunoprecipitates and
readily detected CTCF but not T-bet in CTCF immunoprecipi-
tates (data not shown). Similar results were obtained in EL-4 cells
(which express endogenous CTCF but not endogenous T-bet) in
which epitope-tagged T-bet was overexpressed (data not
shown). Next we considered the possibility that chromatin modi-
fications induced by T-bet (Miller et al., 2008; Wilson et al., 2009)
might promote CTCF occupancy at the Ifng locus. To address
this possibility, we differentiated T-bet-deficient CD4+ T cells in
Th1 conditions in the presence or absence of the histone deace-
tylase inhibitor trichostatin A (TSA), and we compared IFN-g
production in these cells to wild-type Th1 cells. IFN-g secretion
and Ifng mRNA expression were augmented by TSA and were
comparable to wild-type Th1 cells (Figures 7A–7C). However,
TSA treatment did not result in increased occupancy of CTCF
at the Ifng locus (Figure 7D). These results indicate that neither
direct interaction between T-bet and CTCF nor T-bet-induced
histone acetylation account for T-bet-dependent enhancement
of CTCF occupancy.
DISCUSSION
By using an approach to map DHSs and starting with human
cells in which the structural rearrangements that complicate
analysis of the mouse Ifng locus are not present, we identified
a DHS that represents a previously cryptic upstream locus
orchestrator. This element consists of a single CTCF binding
motif and is conserved in all mammals, even in rodents in which
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Naive CD4+ T cells were cultured under Th1 cell-polarizing conditions and transduced on day 1 with a bicistronic retroviral vector expressing GFP and CTCF#1,
CTCF#2, or control (scrambled CTCF#1 sequence) shRNAs. GFP+ cells were purified by flow cytometric cell sorting on day 6, and CTCF mRNA and protein
abundance were determined (A) by real-time RT-PCR normalized to b-actin and expressed as percentage of the control and (B) by immunoblotting with tubulin
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experiments. ***p < 0.005; *p < 0.05.it is present within a sea of nonconserved sequences, which
masked earlier detection by conventional computational
searches for CNSs. This element was occupied by CTCF in situ.
This upstream CTCF-binding element was co-occupied by
cohesins, had insulator activity, and cooperated with two other
CTCF/cohesin-binding elements (one located within the firstintron of Ifng and coinciding with DHSII, and another newly iden-
tified by the presence of a DHS at +119 kb in the human and at
+66 kb in the mouse) to approximate interposed enhancers to
the Ifng promoter in a Th1 cell-specific and CTCF-dependent
manner. In doing so, the upstream and downstream CTCF-
binding elements demarcate a Th1 cell domain surroundingImmunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc. 557
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Figure 5. shRNA-Mediated Gene Targeting of CTCF Impairs Ifng Expression
(A) Intracellular staining for the indicated cytokines in Th1 cells transduced with the control shRNA or CTCF shRNAs #1 or #2. The percentage of IFN-g+ and IL-2+
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Figure 6. Impaired Ifng Expression and Three-Dimensional Organization of the Ifng Locus in T-bet-Deficient Th1 Cells
(A) Concentrations of IFN-g (mean ± SD) in culture supernatants of wild-type (WT) and Tbx21/ CD4+ T cells cultured in Th1 or Th2 cell conditions for 6 days.
(B and C) Relative cross-linking frequencies between Ifng as the fixed anchor fragment and other BglII fragments (B) and between the 70 kb CTCF or +66 kb
CTCF element and the indicated BglII fragments (C) for WT Th1 CD4+ T cells (dashed dark blue lines) and Tbx21/ naive, Th1, and Th2 CD4+ T cells (black, red,
and light blue lines, respectively). Results are presented as in Figure 3.
(D) CTCFChIP in naive, Th1, and Th2 CD4+ T cells fromWTor Tbx21/mice. Results are themean ± SDof two experiments relative toWT naive T cells at70 kb,
which represented 1.05% ± 0.17% of input; only p values (calculated by Student’s t test)% 0.05 are shown. *p < 0.05.Ifng and its enhancers in which intervening nonregulatory
sequences are looped out. This looping segregates Ifng from
the upstream Th17 cytokine genes encoding IL-22 and (in
humans) IL-26 and from other sequences downstream. These
findings are consistent with the emerging evidence that insula-
tors interact with each other to create a physical, spatial, and
functional boundary that separates cis-regulatory elements and
chromatin domains of one locus from its surroundings (Bushey
et al., 2008; Gaszner and Felsenfeld, 2006; Hou et al., 2008).
Within this domain, the +1 kb intronic CTCF-binding element
might in principle act as a barrier to transcription. However,although CTCF can block enhancer-promoter interactions
when bound between these elements, CTCF can be dynamically
evicted from transcribed regions by elongating pol II complexes
(Bushey et al., 2008; Lefevre et al., 2008).
We found that the Ifng locus is largely unstructured in naive
CD4+ T cells and became more compact through chromatin
looping in Th1 cells and more linear in Th2 cells. By contrast,
the Th2 cytokine locus assumes a prepoised conformation in
naive T cells and NK cells, and this conformation is maintained
in resting Th1 and Th2 cells (Spilianakis and Flavell, 2004).
CTCFwas recently shown to bind to four sites in the Th2 cytokineImmunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc. 559
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Figure 7. In T-bet-Deficient Th1 Cells, the Histone Deacetylase Inhibitor Trichostatin A Restores IFN-g Production and 3-Dimensional Locus
Conformation but Not CTCF Occupancy at the Ifng Locus
(A–D) Concentrations of IFN-g in culture supernatants (A), IfngmRNA expression (B), intracellular IFN-g (C), and CTCF ChIP (D) for WT and Tbx21/CD4+ T cells
differentiated in Th1 conditions for 5 days with or without trichostatin A (TSA). Data (mean ± SD) are representative of four independent experiments. *p < 0.05.
(E) Proposed model for the three-dimensional conformation of the Ifng locus. In naive CD4+ T cells, CTCF is bound primarily at 70 kb and T-bet is not bound.
Upon Th1 cell differentiation, T-bet binds to the Ifng promoter and to the CNS34, CNS+1820, and CNS+29 enhancers, and CTCF binds strongly at +1 kb, in
intron 1 of Ifng, and at +66 kb in addition to70 kb. This binding contributes to and is required for the juxtaposition of each of these distal regulatory elements to
Ifng and its promoter. In this active locus conformation, the CNS34 enhancer is in close proximity to Ifng but more distant from the +1 and +66 CTCF-binding
elements. Filled and open lollipops represent methylated and unmethylated CpGs, respectively.locus both in Th1 and Th2 cells (Ribeiro de Almeida et al., 2009),
but whether it contributes to the prepoised conformation of the
locus observed in T and NK cells (Spilianakis and Flavell, 2004)
was not explored. Th2 cell-specific conformational changes
occur when Th2 cells are activated. Activation induces expres-
sion of the architectural factor SATB1 (special AT-rich sequence
binding protein 1), which binds to CNS1, CNS2, and multiple
other sites in the Th2 cytokine locus to drive the formation
of additional chromatin loops and more intimate interactions of
the Il4, Il5, and Il13 promoters with each other and a number of
other cis-regulatory elements (Cai et al., 2006). These interac-
tions are lost and Th2 cytokine expression is compromised
when SATB1 abundance is reduced (Cai et al., 2006). Thus,
SATB1 appears to play a Th2 cell-specific architectural role at560 Immunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc.the Th2 cytokine locus analogous to the Th1 cell-specific effects
of CTCF at the Ifng locus. However, the strategy is somewhat
different—CTCF demarcates boundaries and chaperones inter-
posed enhancers to a single, central target Ifng, whereas SATB1
binds at multiple sites in the Th2 cytokine locus to promote locus
contraction in response to TCR-driven activation of Th2 cells.
What might be the raison d’etre for this strategic difference?
The Th2 cytokine locus may have the luxury of deferring its
conformational changes until cells are activated because no
lineage-forbidden cytokine genes are nearby that might be
inappropriately activated if not constitutively constrained. By
contrast, it may be important for Th1 cells to segregate Ifng
from nearby Th17 cytokines or repressive chromatin even when
at rest. These differences notwithstanding, the findings at the
Immunity
T-bet Conditions CTCF-Dependent Regulation of IfngIfng and Th2 cytokine loci together suggest that the cell type-
specific differences in three-dimensional locus conformation
promoted by CTCF and SATB1, respectively, facilitate cytokine
gene expression, though additional mechanisms may also be
involved.
Our findings are consistent with and illuminate the mecha-
nisms for findings reported recently while our work was being
completed. Ribeiro de Almeida et al. (2009) observed an
50% reduction in IFN-g-producing cells when CD4+ T cells
from CTCF conditionally deficient mice were cultured in Th1 cell
polarizing conditions. However, CTCF occupancy at the Ifng
locus and other possible mechanisms by which CTCF might
facilitate IFN-g production were not assessed, and the possibility
that the difference in IFN-g production was secondary to the
intrathymic developmental bottleneck these T cells experienced
could not be excluded. Hadjur et al. (2009) demonstrated that
cohesins bind with CTCF at the IFNG locus in human Th1 cells
and that cohesins help to promote chromatin looping and IFN-g
production, but did not determine whether CTCF promoted
IFN-g production nor explore the basis for the Th1 cell-specificity
of CTCF and cohesin binding or actions. Our results demonstrate
that CTCF acts to establish a Th1 cell-specific Ifng locus archi-
tecture and to promote Ifng expression as naive CD4+ T cells
differentiate into Th1 effectors and show that these actions of
CTCF and its occupancy at the Ifng locus are T-bet dependent.
CTCF is a ubiquitous insulator and architectural factor. The
vast majority of sites occupied by CTCF throughout the genome
are common to all cell types, suggesting that it plays a general
role in genome organization (Cuddapah et al., 2009; Kim et al.,
2007; Phillips and Corces, 2009; Xie et al., 2007). Nonetheless,
CTCF promoted the formation of an Ifng locus conformation
conducive to robust Ifng expression in a Th1 cell-specific
manner. Cell context-dependent differences in CTCF-mediated
chromatin looping and insulator function have been reported
at the b-globin, H19-Igf2, and MHC class II loci (Ling et al.,
2006; Majumder et al., 2008; Splinter et al., 2006). The context-
dependent effects of CTCF may result from posttranslational
modifications affecting its ability to interact with other factors,
differences in the abundance of such factors, or epigenetic alter-
ations that regulate its binding.
At the Ifng locus, the ability of CTCF to promote a three-dimen-
sional locus architecture conducive to efficient Ifng expression
correlated closely with the extent of its binding. In naive CD4+
T cells, CTCF was bound primarily at the upstream 70 kb
element, and the Th1 cell-specific domain surrounding Ifng was
not yet established. Upon Th1 cell differentiation, T-bet abun-
dance and occupancy at the Ifng promoter at the +1 kb and
+66 kb sites and at other sites within the locus increased and led
to increased occupancy of the +1 kb and +66 kb sites by CTCF
and cohesins. How T-bet promotes CTCF occupancy of these
sites remains uncertain, though it does not appear to do so by
direct interactionwithCTCForbyaugmentinghistoneacetylation
at this locus. Andalthoughour results strongly suggest that CTCF
promotes Th1 cell-specific Ifng locus architecture and expres-
sion is mediated by binding to these three elements, mutation
of these elements will be required to demonstrate this directly.
The data nonetheless show that a key and previously unappre-
ciated Th1 cell-specific regulatory effect of T-bet at the Ifng
locus is to condition the binding of CTCF and thereby convertthis ubiquitous architectural factor into a Th1 cell-specific regu-
lator of chromatin looping at the Ifng locus. This looping in turn
helps to drive the juxtaposition of T-bet-binding enhancers and
the flanking CTCF-binding elements to Ifng and to promote
Ifng expression. These results also illuminate one mechanism
giving rise to the small fraction of CTCF-binding sites in the
genome that are cell lineage specific (Cuddapah et al., 2009;
Kim et al., 2007; Xie et al., 2007) and demonstrate a presumably
widespread mechanism of cooperation between orchestrating
(CTCF) and lineage-specific transcriptional enhancer (T-bet)
factors in cell-specific gene regulation.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 and Tbx21/ mice from the Jackson Laboratory and P25 TCR
transgenic mice (Tamura et al., 2004) were housed in specific-pathogen-free
conditions in the University of Washington Animal Facility. All experiments
were approved by the Institutional Animal Care and Use Committee of the
University of Washington.
Cell Culture
Naive (CD44lo) CD4+ T cells were purified from P25 TCR transgenic mice by
flow cytometric cell sorting and either analyzed directly or stimulated with
30 mg/ml of cognate peptide-25 (United Biochemical Research) in the pres-
ence of antigen-presenting cells (CD4, CD8, and NK1.1-depleted B6 spleno-
cytes), expanded under Th1 or Th2 cell-polarizing conditions for 5 days, and
then analyzed for cytokine and transcription factor expression as described
(Schoenborn et al., 2007). Naive CD4+ Tbx21/ T cells were expanded in
a similar manner with the exception that they were stimulated with CD3 plus
CD28 T cell expander beads (Dynal Biotech). Where indicated, Tbx21/
T cells were expanded in Th1 cell conditions for 5 days in the presence of
trichostatin A (12 nM). For intracellular analysis of T-bet abundance, cells
were stained for 30 min with anti-T-bet (4B10; Santa Cruz) or mouse IgG1 iso-
type (P3; eBioscience) in Hank’s balanced-salt solution containig 1% BSA,
10 mM HEPES, and 0.5% saponin. EL-4 (Schoenborn et al., 2007), AE7 and
D10.G4.1 (Zheng and Flavell, 1997), and G1E-ER (Gregory et al., 1999) cells
weremaintained as described. Human naive (CD45RA+) CD4+ T cells were iso-
lated with an Automacs (Miltenyi), stimulated with human CD3+CD28 T cell
expander beads in Aim V medium (Invitrogen) containing 2% human type
AB serum in Th1 (10 ng/ml huIL-12, 5 mg/ml anti-IL4) or Th2 (10 ng/ml
huIL-4, 10 mg/ml anti-IFN-g) cell conditions, then expanded for 6–7 days in
medium plus IL-2. Studies with human cells were approved by the University
of Washington Human Subjects Division Institutional Review Board.
Digital DNase I Sample Preparation, Library Construction,
and Sequencing
Cells were washed with PBS, pelleted, and resuspended in ice-cold Buffer A
(15 mM Tris-Cl [pH 8.0], 15 mM NaCl, 60 mM KCl, 1 mM EDTA [pH 8.0],
0.5 mM EGTA [pH 8.0], 0.5 mM spermidine). Nuclei were isolated by adding
23 lysis buffer (Buffer A containing 0.2% IGEPAL), mixing by inversion, and
incubating on ice for 8 min. Nuclei were then pelleted, resuspended, and
washed with Buffer A. DNaseI digestions (40–80 U/mL) were carried out for
3 min at 37C, then stop buffer (50 mM Tris-Cl [pH 8.0], 100 mM NaCl,
0.10% SDS, 100 mM EDTA [pH 8.0], 10 mg/mL RNase A) was added followed
by incubation at 55C for 15 min, addition of proteinase K, and overnight incu-
bation at 55C. DNA was purified by gentle phenol chloroform extraction, then
double-cut fragments of 100–500 bp were isolated by sucrose gradient centri-
fugation as described (Sabo et al., 2006) with minor modification. Digital
DNaseI libraries were constructed according to Illumina’s protocol by end
repair of 50 ng of purified DNA, 30 adenine addition, column purification,
adaptor ligation, and 16 cycles of amplification. Amplified libraries were
purified, quantified, and sequenced by the University of Washington, High-
Throughput Genomics Unit with an Illumina Genome Analyzer to produce
18–25 million uniquely mapping 27-mer reads per cell type (Hesselberth
et al., 2009). The 50 end of each uniquely mapping read from a digital DNaseIImmunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc. 561
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cleavage sites in a 150 bp sliding (step 20 bp) window was computed across
the entire genome for each cell type and formatted for display as a track in the
UCSC browser. Additionally, the number of DNaseI cleavages per nucleotide
was computed and formatted for display as a UCSC track.
ChIP, DNA Methylation, and Boundary Element Assays
ChIP was performed with rabbit anti-CTCF (07-729; Millipore), anti-Rad21
(ab992; Abcam), or anti-T-bet (sc-21003; Santa Cruz) and quantified on an
ABI PRISM 7300 system as described (Schoenborn et al., 2007). CpG methyl-
ation in the Ifng locus was quantified by sequencing of genomic DNA after
bisulfite modification and PCR amplification (Schoenborn et al., 2007). Insu-
lator assays were performedwith linearized constructs, as described (Schoen-
born et al., 2007); significance was determined with a two-tailed, unpaired
Student’s t test via Prism 4.0 software.
3C Analysis
The 3C assay was done as described (Dekker, 2006; Tolhuis et al., 2002) with
some modifications. 107 cells in 10 ml of RPMI 1640 + 10% FBS were cross-
linked with 2% formaldehyde for 10 min, after which the reaction was
quenched by addition of glycine (final concentration 0.125M). Cells were lysed
with ice-cold lysis buffer (10 mM Tris [pH 8.0], 10 mM NaCl, 0.2% NP-40)
containing complete protease inhibitor cocktail (Roche) for 45 min. Nuclei
were resuspended in 0.5 ml of restriction enzyme buffer containing 0.3%
SDS then incubated for 1 hr at 37C on a rotator. Triton X-100 was added (final
concentration 1.8%), then nuclei were incubated for 1 hr to sequester the SDS.
Crosslinked DNA was digested overnight with 400 U BglII, SDS was added
(final concentration 1.3%), and the restriction enzyme was inactivated. The
reaction was diluted with 8 ml of ligation buffer (50 mM Tris [pH 8.0], 10 mM
MgCl2, 10mMDTT, 1mMATP, and 1mg/ml bovine serum albumin), and Triton
X-100 was added to 1% followed by incubation for 1 hr on a rotator. DNA frag-
ments were ligated with 4000 U of T4 ligase for 4 hr at 16C followed by 30 min
at RT. Crosslinks were reversed by incubation with proteinase K overnight at
65C. The samples were further incubated for 30 min at 37C with RNase,
and the DNA was purified by phenol extraction and ethanol precipitation.
Ligation products were quantified in triplicate by quantitative TaqMan
real-time PCR as described (Hagege et al., 2007). To correct for differences
in ligation and PCR efficiency between different templates, we used a control
template containing all possible ligation products. Equimolar amounts of three
BAC clones spanning themouse Ifng locus (RP23-401E11, RP23-325C14, and
RP23-55O21) and a BAC spanning the mouse Gapdh locus (RP23-410F11)
were mixed, then digested and ligated as described above; this product was
used as the DNA reference standard. Ligation frequencies between the
analyzed pairs were normalized to those detected between two restriction
fragments in the Gapdh locus. Primers and probes for these assays and all
other assays are listed in Supplemental Experimental Procedures.
Expression of the Zinc Finger Domains of CTCF and EMSA
Mouse CTCF cDNA was PCR amplified and cloned into the pET15b. The
His-tagged CTCF zinc finger domains were expressed in BL21 E. coli, purified
by Ni-NTA resin (QIAGEN), and concentrated by Microcon (Millipore). EMSA
probes were generated as described (Sekimata and Homma, 2004). Binding
was done in 10 ml of binding buffer (10mMHEPES [pH 7.9], 1mMdithiothreitol,
5 mM MgCl2, 0.5 mM ZnCl2, 60 mM KCl, 0.05% Nonidet P-40, 200 ng poly
(dI$dC), 10% glycerol, and 50 mg/ml BSA) for 30 min at RT with the labeled
probe and 2 mg of purified His-tagged CTCF. Unlabeled double-stranded
oligonucleotides were added as competitors at 200-fold molar excess.
Binding reactions were resolved by PAGE followed by autoradiography.
Coimmunoprecipitation Assays
Whole-cell extracts were prepared from primary Th1 cells or from EL-4 cells
that had been transfected with V5 epitope-tagged T-bet expression constructs
as described (Miller et al., 2008) and incubated with antibodies to CTCF
(07-729, Millipore), to T-bet (4B10; Santa Cruz Biotechnologies), or to the V5
epitope (R960-25; Invitrogen). The immunocomplexes were then incubated
with protein G beads for 1–2 hr, washed, and used for immunoblot analysis.562 Immunity 31, 551–564, October 16, 2009 ª2009 Elsevier Inc.CTCF shRNA Retrovirus Production and Transduction
The target sequences for mouse CTCF shRNA (CTCF#1, CTCF#2, and control,
containing scrambled CTCF#1 sequences) were designed according to
protocol (Olson et al., 2006) and are listed in Table S3. These oligonucleotides
were used as templates to perform PCR with primers mir30-f and mir30-r, and
the products were cloned into MSCV-LTR-U6miR30-PIG (Dickins et al., 2005).
Retroviruses were produced by transfecting Phoenix-Eco packaging cells and
used to transduce T cells (Shnyreva et al., 2004). After 5 days of retroviral
transduction, GFP+ cells were isolated by flow cytometric cell sorting and
analyzed. RNA was isolated with the RNeasy kit (QIAGEN), cDNA was synthe-
sized with SuperScript II reverse transcriptase (Invitrogen), and mouse CTCF
mRNA expression was assessed by quantitative real-time PCR with primers
CTCF-f and CTCF-r and normalized to b-actin with primers actin-f and actin-r
(Table S4; Shnyreva et al., 2004). For western blotting, 20 mg of cell lysates
were resolved on 7.5% SDS-PAGE gels, transferred to nitrocellulose
membranes, which were incubated with a 1/500 dilution of mouse monoclonal
anti-CTCF or anti-a-tubulin, HRP-conjugated anti-mouse antibody, then
developed with ECL. Other cells were restimulated with 1 mM ionomycin
(Sigma) and 25 ng/ml PMA (Sigma) for 6 hr for analysis of cytokine production
by ELISA or flow cytometric detection of intracellular cytokine production.
qRT-PCR
Presynthesized TaqMan Gene Expression assays (Applied Biosystems) were
used for amplification of mRNA transcripts of Tbx21 (Mm0045096_m1), Gata3
(Mm00484683_m1), Stat4 (Mm00448890_m1), Il2 (Mm99999222_m1), Cxcr3
(Mm00438259_m1),Ccr5 (Mm01216171_m1),Dyrk2 (Mm01165529_m1),Furin
(Mm00440646_m1), Il12rb2 (Mm00434200_m1), IL22 (Mm00444241_m1),
and Mdm1 (Mm00487650_m1). Target gene value was calculated relative to
eukaryotic 18S rRNA (4319413E; Applied Biosystems) expression.
SUPPLEMENTAL DATA
Supplemental Data include seven figures and ten tables and can be
found with this article online at http://www.cell.com/immunity/supplemental/
S1074-7613(09)00405-1.
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